Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02726581
Title Study of Combinations of Nivolumab, Elotuzumab, Pomalidomide and Dexamethasone in Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

multiple myeloma

Therapies

Elotuzumab

Nivolumab

Dexamethasone + Pomalidomide

Age Groups: adult
Covered Countries USA | ITA | ESP | DEU | CAN | AUT


No variant requirements are available.